Surveillance Study of Somavert Therapy in Patients with Acromegaly

What we are studying

The goal of this outcomes study will be to continue monitoring safety but also to directly focus on clinical (symptoms and quality of life) and biochemical control (IGF-I and glucose). Specifically, data will be collected more systematically related to diabetes control and include additional data on PRO measurements. Data will be collected at baseline and at intervals in accordance with the standard management of patients with acromegaly and in accordance with the recommendations of the Somavert® (pegvisomant) Package Insert (US) or Somavert® (pegvisomant)

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18 - 80

Eligibility Criteria

  • Subjects will be asked to take part in this study if they have a diagnosis of acromegaly a condition caused by too much growth hormone and they are or will be treated with Somavert (also called pegvisomant)

What is involved

  • The type of information that will be collected will include
  • But not be limited to
  • Background information about subjects
  • Such as birth date
  • Medical history
  • Ethnic origin
  • Treatments
  • Height and weight
  • And certain other medical information which will be collected as part of your routine care. Subjects will also be asked to complete questionnaires about their health and general well-being. This research study will also collect information about standard of care blood test results. Subjects will not need to have any special tests or additional procedures because they are taking part in this research study.

Compensation

None

Contact Information

Study Coordinator
Wendy Jenkins, RN BSN, CCRC
Email
wejenkin@wakehealth.edu
Phone
336.716.6438
Principal Investigator
Stephen B. Tatter, MD PhD

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.